A Lymph Node Ratio of 10% Is Predictive of Survival in Stage III Colon Cancer: A French Regional Study

被引:22
作者
Sabbagh, Charles [1 ,12 ,13 ]
Mauvais, Francois [2 ,13 ]
Cosse, Cyril [1 ,15 ]
Rebibo, Lionel [1 ,12 ,13 ]
Joly, Jean-Paul [3 ,13 ]
Dromer, Didier [4 ,13 ]
Aubert, Christine [4 ,13 ]
Carton, Sophie [5 ]
Dron, Bernard [5 ,6 ,13 ]
Dadamessi, Innocenti [5 ,13 ]
Maes, Bernard [13 ]
Perrier, Guillaume [7 ,13 ]
Manaouil, David [8 ,13 ]
Fontaine, Jean-Fran Cois [9 ,13 ]
Gozy, Michel [9 ,13 ]
Panis, Xavier [9 ]
Foncelle, Pierre Henri [10 ,13 ]
de Fresnoy, Hugues [11 ]
Leroux, Fabien [1 ,12 ]
Vaneslander, Pierre [3 ,12 ]
Ghighi, Caroline [14 ]
Regimbeau, Jean-Marc [1 ,12 ,13 ]
机构
[1] Amiens Univ Hosp, Dept Digest Surg, Amiens, France
[2] Beauvais Gen Hosp, Dept Digest Surg, Beauvais, France
[3] Amiens Univ Hosp, Dept Hepatogastroenterol, Amiens, France
[4] Clin St Claude, St Quentin en Yvelines, France
[5] St Quentin Gen Hosp, St Quentin en Yvelines, France
[6] Abbeville Gen Hosp, Abbeville, France
[7] Compiegne Gen Hosp, Compiegne, France
[8] Clin Pauchet, Amiens, France
[9] Polyclin Picardie, Amiens, France
[10] Peronne Gen Hosp, Peronne, France
[11] Laon Gen Hosp, Laon, France
[12] Jules Verne Univ Picardie, Amiens, France
[13] Assoc Picarde Cancerol Digest, Amiens, France
[14] Dept Pathol, Abbeville, France
[15] Amiens Univ Hosp, Direct Clin Res, Amiens, France
关键词
Colon cancer; Lymph node ratio; Surgery; Survival; COLORECTAL-CANCER; PROGNOSIS; NUMBER;
D O I
10.9738/INTSURG-D-13-00052.1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Lymph node ratio (LNR) (positive lymph nodes/sampled lymph nodes) is predictive of survival in colon cancer. The aim of the present study was to validate the LNR as a prognostic factor and to determine the optimum LNR cutoff for distinguishing between "good prognosis'' and "poor prognosis'' colon cancer patients. From January 2003 to December 2007, patients with TNM stage III colon cancer operated on with at least of 3 years of follow-up and not lost to follow-up were included in this retrospective study. The two primary endpoints were 3-year overall survival (OS) and disease-free survival (DFS) as a function of the LNR groups and the cutoff. One hundred seventy-eight patients were included. There was no correlation between the LNR group and 3-year OS (P = 0.06) and a significant correlation between the LNR group and 3-year DFS (P = 0.03). The optimal LNR cutoff of 10% was significantly correlated with 3-year OS (P = 0.02) and DFS (P = 0.02). The LNR was not an accurate prognostic factor when fewer than 12 lymph nodes were sampled. Clarification and simplification of the LNR classification are prerequisites for use of this system in randomized control trials. An LNR of 10% appears to be the optimal cutoff.
引用
收藏
页码:344 / 353
页数:10
相关论文
共 23 条
[1]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[2]   Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes [J].
Berger, AC ;
Sigurdson, ER ;
LeVoyer, T ;
Hanlon, A ;
Mayer, RJ ;
Macdonald, JS ;
Catalano, PJ ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8706-8712
[3]   Prognostic Value of the Lymph Node Ratio in Stage III Colorectal Cancer: A Systematic Review [J].
Ceelen, W. ;
Van Nieuwenhove, Y. ;
Pattyn, P. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (11) :2847-2855
[4]   Lymph node evaluation and survival after curative resection of colon cancer: Systematic review [J].
Chang, George J. ;
Rodriguez-Bigas, Miguel A. ;
Skibber, John M. ;
Moyer, Virginia A. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (06) :433-441
[5]   Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer [J].
Chin, Chih-Chien ;
Wang, Jeng-Yi ;
Yeh, Chien-Yuh ;
Kuo, Yi-Hung ;
Huang, Wen-Shih ;
Yeh, Chung-Hung .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (11) :1297-1302
[6]   Metastatic lymph node size and colorectal cancer prognosis [J].
Dhar, DK ;
Yoshimura, H ;
Kinukawa, N ;
Maruyama, R ;
Tachibana, M ;
Kohno, H ;
Kubota, H ;
Nagasue, N .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (01) :20-28
[7]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[8]   Colorectal carcinoma with potentially resectable metastases:: Factors associated with the failure of curative schedule [J].
Fuks, D. ;
Cook, M. -C. ;
Brehant, O. ;
Henegar, A. ;
Dumont, F. ;
Chatelain, D. ;
Yzet, T. ;
Mulieri, G. ;
Joly, J. -P. ;
NGuyen-Khac, E. ;
Dupas, J. -L. ;
Mauvais, F. ;
Verhaeghe, P. ;
Regimbeau, J. -M. .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (04) :390-400
[9]  
GERCOR, 2009, COMB CHEM 3 MONTHS 6
[10]  
Grzebieniak Zygmunt, 2004, Przegl Lek, V61, P43